Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
The man who allegedly drove his car into pedestrians on the Ile d’Oleron has said that he regrets his actions, according to the local prosecutor....
Read More
Time is running out for the marine animals at Marineland in Antibes. On Thursday, 6 November 2025, France’s Minister for Ecological Transition, Mathie...
Read More
A highly critical report into the operation of border facilities for migrants in Menton has been released today. Inspectors carried out an unannounced...
Read More
A 35-year-old man was arrested on Wednesday after deliberately driving into pedestrians and cyclists on the island of Oléron, off France’s western coa...
Read More
Five people have been injured, two of them seriously, after a man deliberately drove into pedestrians this morning in the Charente-Maritime department...
Read More
